Glooko announced today that it launched its Insulin Pump Settings Electronic Health Record (EHR) integration capability.
Palo Alto, California-based Glooko says the first-of-its-kind capability within its latest software release visualizes critical insulin pump configuration data directly into the clinical workflow.
The company says that visibility of pump settings provides essential clinical context for clinics caring for those with diabetes on insulin pump therapy. Settings include basal schedules, insulin-to-carb ratios, insulin sensitivity factors, blood glucose target ranges, closed-loop status and active insulin time. All of these help care teams understand insulin delivery and determine the need for therapy adjustments.
According to Glooko, much of this information typically lives outside the EHR, isolated in external software, PDFs or screenshots. This requires clinicians and staff to toggle between systems and manually transcribe data or copy and paste pump settings into visit notes.
Now, Glooko’s Pump Settings EHR offering can replace the fragmented workflow with structured, discrete pump settings data. With data visualized in EHR flowsheets, clinicians can pull it automatically into their documentation using SmartTex-style workflows.
Glooko said its offering adds a specialized, device-agnostic diabetes layer for EHRs. It strengthens the company’s overall EHR integration capabilities, with a launch to come as part of its Web 26.2 and Mobile 16.16 product release next week.
The company’s existing diabetes management platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight.
Commentary from Glooko officials
Dr. Mark Clements, chief medical and strategy officer at Glooko, said:
“Pump settings are the source of truth for how an insulin pump is delivering therapy; however, traditional documentation requires manual transcription of up to 24 different data points into the EHR. When clinicians can see settings such as basal rates, insulin-to-carbohydrate ratios, correction factors, active insulin time and closed-loop status in the same workflow as glucose data and the patient note, the visit becomes less about finding and transcribing information and more about acting on it. This integration, which is unique to Glooko, gives care teams a more complete view of insulin therapy today and creates the structured data foundation for more advanced clinical decision support in the future—where discrete pump settings, glucose trends and other diabetes data can work together to surface more timely, actionable insights. By reducing reliance on incomplete, stale or manually transcribed information, Glooko is helping clinics make therapy adjustments with greater context, consistency and confidence.”
Rich Glenn, president of Connected Care at Glooko, said:
“Health systems are asking for diabetes data to be more connected, usable and embedded in the way care is actually delivered. By bringing device-agnostic pump settings into EHR flowsheets, Glooko is helping clinics move beyond fragmented portals and manual documentation toward a more connected care experience for providers and people with diabetes.”
